Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders.

Brand BA, Boer AJ, de Boer JN, Bozaoglu K, Morris K, Rossell S, Sommer IEC.

DOI: 10.1016/j.psyneuen.2024.107274
Published: 2025-01-03
Container: Psychoneuroendocrinology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.psyneuen.2024.107274,
  title = {Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders.},
  author = {Brand BA and  Boer AJ and  de Boer JN and  Bozaoglu K and  Morris K and  Rossell S and  Sommer IEC.},
  year = {2025},
  journal = {Psychoneuroendocrinology},
  doi = {10.1016/j.psyneuen.2024.107274},
  url = {https://doi.org/10.1016/j.psyneuen.2024.107274}
}

RIS

TY  - JOUR
TI  - Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders.
AU  - Brand BA
AU  -  Boer AJ
AU  -  de Boer JN
AU  -  Bozaoglu K
AU  -  Morris K
AU  -  Rossell S
AU  -  Sommer IEC.
PY  - 2025
JO  - Psychoneuroendocrinology
DO  - 10.1016/j.psyneuen.2024.107274
UR  - https://doi.org/10.1016/j.psyneuen.2024.107274
ER  -

APA

BA, B., AJ, B., JN, D. B., K, B., K, M., S, R., & IEC., S. (2025). Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders.. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2024.107274

Source records

europe-pmc · retrieved 2026-11-10T14:02:01.180Z